GSK, Sanofi shares jump as Zantac lawsuits dismissed
Reuters, 07 Dec 2022
Shares of GSK and Sanofi surged in early trading following the dismissal of thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer.
#News #Reuters #newsfeed #pharma #shares #Zantac
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en